A096530 Stock Overview
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Seegene, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩22,200.00 |
| 52 Week High | ₩30,600.00 |
| 52 Week Low | ₩19,040.00 |
| Beta | -1.17 |
| 1 Month Change | -11.55% |
| 3 Month Change | -3.06% |
| 1 Year Change | -8.07% |
| 3 Year Change | -77.32% |
| 5 Year Change | 88.94% |
| Change since IPO | 427.73% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of Seegene, Inc. (KOSDAQ:096530)
Mar 07
Is Seegene, Inc. (KOSDAQ:096530) Trading At A 32% Discount?
May 06I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease
Mar 15Does Seegene (KOSDAQ:096530) Have A Healthy Balance Sheet?
Feb 25Seegene (KOSDAQ:096530) Is Growing Earnings But Are They A Good Guide?
Feb 08
What Is The Ownership Structure Like For Seegene, Inc. (KOSDAQ:096530)?
Jan 22Calculating The Fair Value Of Seegene, Inc. (KOSDAQ:096530)
Jan 07Declining Stock and Solid Fundamentals: Is The Market Wrong About Seegene, Inc. (KOSDAQ:096530)?
Dec 23Can You Imagine How Elated Seegene's (KOSDAQ:096530) Shareholders Feel About Its 656% Share Price Gain?
Dec 08I Ran A Stock Scan For Earnings Growth And Seegene (KOSDAQ:096530) Passed With Ease
Nov 24Shareholder Returns
| A096530 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | 5.7% | 5.4% | 3.4% |
| 1Y | -8.1% | 6.7% | 7.1% |
Return vs Industry: A096530 underperformed the KR Biotechs industry which returned 6.6% over the past year.
Return vs Market: A096530 underperformed the KR Market which returned 4.7% over the past year.
Price Volatility
| A096530 volatility | |
|---|---|
| A096530 Average Weekly Movement | 8.7% |
| Biotechs Industry Average Movement | 8.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A096530's share price has been volatile over the past 3 months.
Volatility Over Time: A096530's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,008 | Jong-Yoon Chun | www.seegene.com |
Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes.
Seegene, Inc. Fundamentals Summary
| A096530 fundamental statistics | |
|---|---|
| Market cap | ₩1.02t |
| Earnings (TTM) | ₩669.01m |
| Revenue (TTM) | ₩367.38b |
1,528x
P/E Ratio2.8x
P/S RatioIs A096530 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A096530 income statement (TTM) | |
|---|---|
| Revenue | ₩367.38b |
| Cost of Revenue | ₩155.47b |
| Gross Profit | ₩211.91b |
| Other Expenses | ₩211.24b |
| Earnings | ₩669.01m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 14.53 |
| Gross Margin | 57.68% |
| Net Profit Margin | 0.18% |
| Debt/Equity Ratio | 7.5% |
How did A096530 perform over the long term?
See historical performance and comparison